Search Results
May 29, 2026, 09:25 ET New Acer Tablets Plus AI and AR Glasses Expand On-the-Go Capabilities
7400 SoC paired with Android 16.Acer Iconia Duo D12: Capable Tablet for Seamless Creativity and ProductivityThe Acer Iconia Duo D12 (D12-11M) brings the productivity and creative benefits of the 3:2
More news about: Acer
May 29, 2026, 09:20 ET Neues Branding, neue Ära: Fox ESS positioniert sich vor der SNEC neu
diesjährigen SNEC PV Power Expo in Shanghai: Fox ESS präsentiert erstmals einen vollständig neu gestalteten interaktiven Markenbereich am Stand 7.1H-D610. Zusätzlich veranstaltet das Unternehmen am 2. Juni ein eigenes „Fox Party"-Event. Besucher erhalten dort die Möglichkeit, die neue Markenidentität
More news about: Fox ESS
May 29, 2026, 09:20 ET Acer Presents Latest Visual Product Lineup Including QD-OLED Monitors
USB (Type A 2.0) x 1, share output portRS232 (D-sub) x 1Dimensions
More news about: Acer
May 29, 2026, 09:15 ET Acer's New Predator and Nitro Monitors Bring Gaming Experiences to Life
Features 3D experiences, DFR technology, 5K clarity, anti-tearing, and 500 Hz refresh rates made accessibleEditor's SummaryThe Predator XB273K 3D monitor brings immersive gaming experiences to life by combining 2D-to-3D capabilities, 4K resolution, a 180
More news about: Acer
May 29, 2026, 09:10 ET Acer Introduces Predator Helios 18 AI: The Ultimate Gaming Laptop
NVIDIA® GeForce RTX™ 5090 Laptop GPU, 6th Gen Predator AeroBlade 3D Fans, and patented Predator Vox audio.The Acer Nitro 16 is the first Acer gaming laptop to feature up to an AMD Ryzen™ 9 9955HX3D processor for high-powered mobile gaming experiences; it also offers up to an
More news about: Acer
May 29, 2026, 09:08 ET Innogen to Present Phase IIb ENLIGHT Study Results for Efsubaglutide Alfa at the 2026 ADA Scientific Sessions
PharmaceuticalsFounded in 2014, Innogen (HK.2591) focuses on innovative metabolic disease drugs, with fully proprietary pipelines covering T1D, obesity, MASH, and AD, supported by global IP and patent portfolios. Its core product, Efsubaglutide Alfa (a next-generation human-derived ultra-long-acting
More news about: Innogen Pharmaceuticals
May 29, 2026, 09:05 ET Acer Expands Lineup of Aspire AI Copilot+ PCs With New Laptops and All-in-Ones
the latest processors.The models powered by AMD (C27D-GGP, C24D-GGP) feature the latest AMD Ryzen™ AI 400 Series processors based on the advanced "Zen 5" architecture, paired with up to AMD Radeon™ 880M Graphics,
More news about: Acer
May 29, 2026, 09:00 ET Acer Launches New Swift Air 14 Powered by Latest Intel Core Series 3 Processors
Dimensions/Weight312.8 (W) x 231.6 (D) x 16.9/17.1 (H) mm, 12.31 (W) x 9.12 (D) x 0.67 inches1.40 kg
More news about: Acer
May 29, 2026, 09:00 ET SKIA HEAD: AR Surgical Guidance Receives FDA 510(k) Clearance, Eyes U.S. Expansion with Structure Partnership
SKIA HEAD is a tablet-based platform. The system converts preoperative medical imaging data into high-fidelity 3D anatomical reconstructions. These models are then projected directly onto the patient's body in real time, allowing surgeons to see beyond the surface
More news about: SKIA
May 29, 2026, 09:00 ET Rokt Appoints Bill Barton as Chief Operating Officer Overseeing People, Security and Legal
University."Bill has spent his career solving hard problems at the intersection of technology and human systems, from building Alexa to leading R&D here at Rokt," said Bruce Buchanan, CEO, Rokt. "The COO role sits at the intersection of our people, our risk posture, and our ability to operate at
More news about: ROKT Pte. Ltd.
May 29, 2026, 09:00 ET The $13 Million Company Teaching the Immune System to Hunt Cancer
patients, a platform licensed from a top-tier research university, a mechanism the biggest players in immuno-oncology are validating with their own R&D budgets, and a pair of catalysts — GTB-3650 data and GTB-5550 progress — both expected in the second half of 2026.That is the
More news about: USA News Group
May 29, 2026, 08:30 ET Dolby and rednote Bring More Immersive Storytelling to Video Content with Dolby Atmos
Dolby OptiView.Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema and the double-D symbol are among the registered and unregistered trademarks of Dolby Laboratories in the United States and/or other countries. Other trademarks remain
More news about: Dolby Laboratories, Inc.
May 29, 2026, 08:18 ET New TECVAYLI® (teclistamab-cqyv) data demonstrate superior progression-free and overall survival as early as first relapse in multiple myeloma
https://www.cancer.org/cancer/types/multiple-myeloma/detection-diagnosis-staging/detection.html9 Kazandjian D. Multiple myeloma epidemiology and survival: a unique malignancy. J Clin Oncol. 2018;36(15):1479–1487.
More news about: Johnson & Johnson
May 29, 2026, 08:15 ET Xtep Recognized for Leading Position in the global running shoes market in 2025 as Industry Advances Toward Professionalization and Scenario Segmentation
Since establishing its strategic focus on running in 2007, Xtep has consistently deepened its footprint in the running track. Driven by technological R&D, oriented by runner needs, and supported by professional services, Xtep has constructed an industry-leading professional running ecosystem characterized
More news about: Xtep
May 29, 2026, 08:15 ET PeproMene Bio annonce une présentation orale à l'EHA 2026 mettant en évidence un profil de sécurité favorable et des réponses durables avec la PMB-CT01 (thérapie CAR-T anti-BAFF-R) dans les lymphomes à cellules B, y compris après l'échec d'une thérapie CAR-T CD19 antérieure
confrontés à un important besoin médical non satisfait, les options thérapeutiques restantes étant très limitées », déclare Larry W. Kwak, M.D., Ph. D., fondateur scientifique de PeproMene Bio. « Ces réponses complètes durables valident cliniquement le BAFF-R en tant que nouvelle cible, tandis que le
More news about: PeproMene Bio, Inc.
May 29, 2026, 08:00 ET SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund
billion (approximately USD 230 million) in long-term, low-interest financing through the Korea Growth Fund program. The funds will be utilized for R&D, commercialization preparation, and manufacturing capability enhancement for 'GBP410,' SK bioscience's and Sanofi's 21-valent pneumococcal conjugate
More news about: SK bioscience
May 29, 2026, 08:00 ET 현대자동차, 2026 FIFA 월드컵(FIFA World Cup 2026™)을 앞두고 보스턴 다이내믹스(Boston Dynamics)의 아틀라스(Atlas)를 주역으로 내세운 "축구 교실" 캠페인 개시
content:https://www.prnewswire.com/kr/news-releases/uD604uB300uC790uB3D9uCC28u002Cu002Du0032u0030u0032u0036u002Du0066u0069u0066u0061u002DuC6D4uB4DCuCEF5u0028u0066u0069u0066u0061u002Du0077u006F-302785344.htmlSOURCE
More news about: Hyundai Motor Company
![PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358](https://mma.prnewswire.com/media/2700185/PharmaLogic_Holdings_Corp_Logo.jpg){kind=logo}
May 29, 2026, 08:00 ET PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358
currently employs a growing team of multidisciplinary experts with backgrounds in radiopharmaceutical discovery and development. Ratio's proprietary R&D platforms, Trillium™ and Macropa™, enable the development of fit-for-purpose heterobifunctional radiopharmaceuticals for therapy and imaging that possess
More news about: PharmaLogic Holdings Corp
![Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358](https://mma.prnewswire.com/media/2682145/Ratio_Therapeutics_Logo.jpg){kind=logo}
May 29, 2026, 08:00 ET Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358
currently employs a growing team of multidisciplinary experts with backgrounds in radiopharmaceutical discovery and development. Ratio's proprietary R&D platforms, Trillium™ and Macropa™, enable the development of fit-for-purpose heterobifunctional radiopharmaceuticals for therapy and imaging that possess
More news about: Ratio Therapeutics Inc.
May 29, 2026, 07:08 ET Zoomlion acelera el despliegue global de maquinaria agrícola con avances en productos híbridos e inteligentes
https://mma.prnewswire.com/media/2990497/231acf39e33f13402c81004afd388d54.jpg
More news about: Zoomlion
May 29, 2026, 07:00 ET COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
engaging with potential strategic partners to support the next phase of development and future commercialization activities.""With respect to our 3D bioprinting activities, during the first quarter we launched BioFlex, a ready-to-print rhCollagen-based kit optimized for high-resolution DLP bioprinting
More news about: CollPlant
May 29, 2026, 07:00 ET Alaw Therapeutics Announces Two Major Pipeline Milestones Advancing Brain-Penetrant CDK Oncology Programs
development candidate, with first-in-human clinical studies planned for Q4 2026.AL-433 targets tumors driven by dysregulation of the CDK4-cyclin D1-Rb-E2F axis, a central regulator of G1-to-S phase cell-cycle progression frequently altered across aggressive solid tumors.The program is designed
More news about: Alaw Therapeutics
May 29, 2026, 06:39 ET Monport Laser Advanced Metal Engraving Solutions for Germany with GM Pro and GT Fiber Laser Series
with speeds up to 10,000 mm/s and 0.01 mm precision. It features one-touch autofocus and upgraded galvanometer optics for stable deep engraving and 3D relief work.It also supports MOPA
More news about: Monport Laser
May 29, 2026, 06:03 ET Monport Laser Showcases Upgraded GA Series and GT Series MOPA Fiber Laser Machines for High-Speed Color Metal Engraving
large-scale manufacturing operations.Built for precision-driven workflows, the upgraded lineup supports high-speed engraving, color marking, deep 3D relief carving, thin-metal cutting, and industrial marking across materials including stainless steel, aluminum, brass, titanium, acrylic, slate, hard
More news about: Monport
May 29, 2026, 06:00 ET iyO Secures Backing of Leading Litigation Funder for Intellectual Property Theft Case Against OpenAI
trademark."iyO has prevailed at every substantive stage of these proceedings to date, most recently with the preliminary injunction issued in April," said Andrew D. Skale, co-lead counsel for iyO and a partner at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo. "The disclosure of a litigation funder is required by
More news about: iyO, Inc.